Nexalin Technology, Inc. (NXL) Net Sales Margin

Corporate emblem and logo of Nexalin Technology Inc (NXL)

Nexalin Technology, Inc. (NXL) develops patented microcurrent systems to combat insomnia and depression. Production is based on non-invasive neurostimulation of psychiatric pathologies. The startup is currently deploying equipment in US clinics following FDA approval. On GURU.Markets, net sales profitability confirms this data, where -3380.60 indicates the level of this metric.

Nexalin Technology (NXL) - Net Profit Rate from 04/28/2023 to 11/19/2026

Analytical breakdowns for Nexalin Technology, Inc.

- share price and expert price forecast:
Fundamental valuation:Nexalin Technology, Inc.
Manufactured product of nexalin.com

Sales margins serve as a fundamental filter to protect capital from operational risks. Analyzing the net profit margin of a company allows for the visualization of cost management efficiency. This metric is calculated as the ratio of net income to revenue, measuring the share of real income from every dollar of sales. For Nexalin Technology, Inc. (NXL), this metric reflects the business's resilience to logistical disruptions. Geopolitical instability in Asia could increase costs, which would immediately reduce final profitability.